Gland Pharma
- Specialty generic injectables company with leadership position in Low Molecular Weight Heparin
- Pioneered Heparin technology in India
- Sales in India, US and 55 other countries
- USFDA approved manufacturing facilities for a diversified portfolio of products
- Strong formulation development capabilities, with an R&D team of ~100 scientists
- The Fund has exited this investment